EMVision Medical Devices (ASX:EMV) boosts cash before clinical trials
- EMVision Medical Devices (EMV) has boosted its cash reserves over the last quarter ahead of clinical trials
- The company's quarterly report for December outlined a $3.7 million increase in cash reserves to a total of $6.8 million
- This boost was mostly thanks to a $4.5 million share placement
EMVision Medical Devices (ASX:EMV) boosts cash before clinical...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.12 |
Change
-0.040(1.85%) |
Mkt cap ! $181.2M | |||
| Open | High | Low | Value | Volume |
| $2.16 | $2.16 | $2.07 | $69.20K | 32.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | $2.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.14 | 5000 | 1 |
View Market Depth
| Last trade - 15.38pm 19/09/2025 (20 minute delay) ? |
| EMV (ASX) Chart |